News
State's Health Outreach and Prevention program will end June 30 after federal funding cuts to HIV outreach and prevention ...
Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...
UNAIDS Executive Director, Winnie Byanyima has warned of the dire consequences of aid cuts to HIV/AIDS by President Donald Trump. She says a pandemic that has been on decline could re surge. “The ...
From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?
The event — which kicked off on the first day of Pride Month this year — is among the oldest cycling fundraisers for HIV and ...
The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in ...
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results